Found 7 matching trials
The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema PHASE2 The purpose of this study is to evaluate the safety and efficacy of AKB-977...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Assess the Absorption, Metabolism, Excretion and Pharmacokinetics of [14C]-AKB-9778 PHASE1 Open-label, single-dose, Phase 1 study to assess the absorption, metabolism...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema PHASE1 The purpose of this study is to evaluate the safety, pharmacokinetics, phar...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution PHASE1 The purpose of this Phase 1b study is to evaluate the safety, tolerability,...
Show More Learn More & Join Trial
The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) PHASE2 The purpose of this study is to evaluate the safety and efficacy of subcuta...
Show More Location
Arizona Retina and Vitreous Consultants
Learn More & Join Trial
Open Label Study to Assess the Efficacy and Safety of AKB-9778 in Subjects With Macular Edema Due to RVO PHASE2 Phase 2a open-label study to assess the efficacy and safety of subcutaneous...
Show More Location
Wilmer Eye Institute
Learn More & Join Trial
Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma PHASE2 This is a phase 2, double masked, randomized, multi-center, parallel-group,...
Show More Location
United Medical Research Institute
Learn More & Join Trial